Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Squadrilli · SciRah

Researcher profile · Semantic Scholar

A. Squadrilli

Share profile

A. Squadrilli — researcher profile on SciRah

h-index: 12
Works: 26
Citations: 658

Most-cited papers

L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC.
M. Bersanelli, R. Minari, P. Bordi, L. Gnetti +8 more
2016Journal of Thoracic Oncology146 citations Open access
Semantic Scholar
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients.
G. Mazzaschi, R. Minari, A. Zecca, A. Cavazzoni +14 more
2020Lung Cancer102 citations
Semantic Scholar
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
S. La Monica, R. Minari, D. Cretella, L. Flammini +15 more
2019Journal of experimental & clinical cancer research : CR58 citations Open access
Semantic Scholar
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors
F. Dall'Olio, F. Abbati, F. Facchinetti, M. Massucci +6 more
2020Therapeutic Advances in Medical Oncology55 citations Open access
Semantic Scholar
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC.
P. Bordi, M. Del Re, R. Minari, E. Rofi +14 more
2019Lung Cancer50 citations Open access
Semantic Scholar
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non‐small cell lung cancer patients
C. Bozzetti, R. Nizzoli, M. Tiseo, A. Squadrilli +13 more
2015Diagnostic Cytopathology43 citations
Semantic Scholar
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab.
F. Facchinetti, M. Veneziani, S. Buti, F. Gelsomino +12 more
2018Immunotherapy40 citations
Semantic Scholar
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC.
R. Minari, P. Bordi, S. La Monica, A. Squadrilli +9 more
2018Journal of Thoracic Oncology37 citations Open access
Semantic Scholar
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC
M. Cinausero, N. Laprovitera, G. Maglio, L. Gerratana +12 more
2019Therapeutic Advances in Medical Oncology35 citations Open access
Semantic Scholar
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: a case report
R. Minari, L. Gnetti, C. Lagrasta, A. Squadrilli +8 more
2020Translational Lung Cancer Research15 citations Open access
Semantic Scholar
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
F. Negri, C. Bozzetti, G. Pedrazzi, C. Azzoni +14 more
2019Oncology Report15 citations Open access
Semantic Scholar
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method
C. Bozzetti, F. Quaini, A. Squadrilli, M. Tiseo +21 more
2015PLoS ONE15 citations Open access
Semantic Scholar
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature
M. Verzè, R. Minari, L. Gnetti, P. Bordi +13 more
2021Cancers12 citations Open access
Semantic Scholar
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors
R. Minari, F. Bonatti, G. Mazzaschi, A. Dodi +14 more
2021Tumori11 citations
Semantic Scholar
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers
C. Tommasi, Benedetta Pellegrino, D. Boggiani, A. Sikokis +12 more
2021Frontiers in Oncology10 citations Open access
Semantic Scholar
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer.
C. Bozzetti, A. Squadrilli, R. Nizzoli, C. Lagrasta +11 more
2020Immunotherapy8 citations
Semantic Scholar
Fingerprint Change: Not Visible, But Tangible
F. Negri, A. De Giorgi, C. Bozzetti, A. Squadrilli +4 more
2017Journal of Forensic Sciences5 citations
Semantic Scholar
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic non-squamous NSCLC.
M. Cinausero, N. Laprovitera, G. De Maglio, L. Gerratana +11 more
2019Annals of Oncology2 citations Open access
Semantic Scholar
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab.
M. Tiseo, F. Facchinetti, S. Buti, F. Gelsomino +12 more
2017Annals of Oncology1 citations Open access
Semantic Scholar
Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC
G. Mazzaschi, R. Minari, V. Ferri, L. Gnetti +12 more
20190 citations Open access
Semantic Scholar
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer
F. Negri, C. Bozzetti, G. Pedrazzi, C. Azzoni +18 more
20170 citations Open access
Semantic Scholar
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with nivolumab.
M. Tiseo, M. Veneziani, F. Gelsomino, S. Buti +12 more
20170 citations
Semantic Scholar
30PD_PRCirculating immune-profile as predictor of outcome in NSCLC patients treated with nivolumab
M. Tiseo, M. Veneziani, F. Gelsomino, F. Facchinetti +6 more
20170 citations Open access
Semantic Scholar
1640P PI3K/RICTOR-mTORC2 axis as a driver of prognosis and potential druggable target in squamous cell lung carcinoma (SqCLC)
F. Facchinetti, F. Gelsomino, S. Buti, M. Veneziani +41 more
20170 citations
Semantic Scholar
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients.
F. Negri, C. Bozzetti, C. Azzoni, L. Bottarelli +11 more
20160 citations
Semantic Scholar
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy
F. Negri, C. Bozzetti, C. Azzoni, L. Bottarelli +12 more
20160 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Tiseo×16
Invite
M. Tiseo — researcher profile on SciRah
P. Bordi×13
Invite
P. Bordi — researcher profile on SciRah
A. Ardizzoni×13
Invite
A. Ardizzoni — researcher profile on SciRah
S. Buti×12
Invite
S. Buti — researcher profile on SciRah

×11

Invite

C. Lagrasta — researcher profile on SciRah

L. Bottarelli×10

Invite

L. Bottarelli — researcher profile on SciRah

Invite

A. Cosenza — researcher profile on SciRah

Invite

L. Ferri — researcher profile on SciRah

Invite

C. Azzoni — researcher profile on SciRah

Invite

R. Minari — researcher profile on SciRah

Invite

L. Gnetti — researcher profile on SciRah

Invite

C. Bozzetti — researcher profile on SciRah